Arrowhead Pharmaceuticals, Inc. (ARWR)
62.75
+2.01
(+3.31%)
USD |
NASDAQ |
Oct 09, 16:00
62.58
-0.17
(-0.27%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Free Cash Flow (Quarterly) : -181.32M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -181.32M |
| March 31, 2026 | 81.88M |
| December 31, 2025 | 11.33M |
| September 30, 2025 | 13.00M |
| June 30, 2025 | -152.08M |
| March 31, 2025 | 454.76M |
| December 31, 2024 | -158.79M |
| September 30, 2024 | -161.50M |
| June 30, 2024 | -129.87M |
| March 31, 2024 | -126.45M |
| December 31, 2023 | -186.50M |
| September 30, 2023 | -89.16M |
| June 30, 2023 | -68.05M |
| March 31, 2023 | -58.98M |
| December 31, 2022 | -114.43M |
| September 30, 2022 | -101.38M |
| June 30, 2022 | -78.38M |
| March 31, 2022 | 57.98M |
| December 31, 2021 | -67.12M |
| September 30, 2021 | -32.32M |
| June 30, 2021 | -33.54M |
| March 31, 2021 | 256.71M |
| December 31, 2020 | -43.19M |
| September 30, 2020 | -12.73M |
| June 30, 2020 | -35.57M |
| Date | Value |
|---|---|
| March 31, 2020 | -31.19M |
| December 31, 2019 | -27.85M |
| September 30, 2019 | 5.979M |
| June 30, 2019 | 7.303M |
| March 31, 2019 | -19.80M |
| December 31, 2018 | 167.55M |
| September 30, 2018 | -3.390M |
| June 30, 2018 | -14.61M |
| March 31, 2018 | -15.82M |
| December 31, 2017 | -14.83M |
| September 30, 2017 | -9.311M |
| June 30, 2017 | -11.57M |
| March 31, 2017 | -15.68M |
| December 31, 2016 | 4.704M |
| September 30, 2016 | -12.89M |
| June 30, 2016 | -19.00M |
| March 31, 2016 | -14.84M |
| December 31, 2015 | -21.55M |
| September 30, 2015 | -12.86M |
| June 30, 2015 | -13.40M |
| March 31, 2015 | -16.67M |
| December 31, 2014 | -24.75M |
| September 30, 2014 | -11.39M |
| June 30, 2014 | -10.42M |
| March 31, 2014 | -8.189M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Moderna, Inc. | -563.00M |
| Sarepta Therapeutics, Inc. | 196.52M |
| Revolution Medicines, Inc. | -389.60M |
| Intellia Therapeutics, Inc. | -84.92M |
| Denali Therapeutics, Inc. | -126.61M |